2024
- Bioada received $150K grant from Microsoft Azure
- Bioada published: Unveiling Chemotherapy’s Impact on Lung Cancer through Single-Cell Transcriptomics
- Bioada published: Comparing Single-Cell Transcriptomes of Blood and Cerebrospinal Fluid Leukocytes in Multiple Sclerosis
- Bioada published: Unlocking the Treatment of Facioscapulohumeral Muscular Dystrophy Type 2: The Bisphenol Connection
- Bioada published: A Novel Perspective on Genes Driving Metastatic Pancreatic Cancer Revealed by Single-cell RNA Sequencing
- Bioada published: Insights from Single-Cell RNA-seq: Identifying the Actin Gene Family as Novel Drivers in Parkinson’s Disease
- Bioada published: CD83 Receptor Unveiled as a Therapeutic Target in Metastatic Breast Cancer through Single-Cell RNA-Seq
- Bioada published: A Short Essay on Data, Probability, Randomness and Uncertainty
2023
- Bioada published: Assessing Facioscapulohumeral Muscular Dystrophy through Comparative Analysis of Bulk and Single-Cell Transcriptomes
- Bioada published: Connecting Cancers to Chromosomal Locations Through Copy Number Variations
- Revolutionizing Precision Medicine – University of Montenegro
- Demystifying Artificial Intelligence, Machine Learning, and Data Science – Mediteran University
- Artificial Intelligence in Biomarker and Drug Discovery – Technopolis
2022
- Data Science for Biomarkers Discovery – ISCBacademy Tutorial
- Bioada is collaborating with Cancer Hacker Lab
- Bioada is collaborating with Stanford University Research to the People
- Bioada is collaborating with RebootRx
- Bioada is collaborating with CancerCommons
- Bioada achieved the best results in p1RCC hackathon
- Bioada received $50K grant from Microsoft Azure
- Bioada received $50K in funding from ADDI
- Bioada received $100K loan from BDC (Business Development Bank of Canada)
- Bioada has become a MaRS (North America’s Largest Innovation Hub) supported venture